Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations

por Efrati, Shai, Catalogna, Merav, Abu Hamad, Ramzia, Hadanny, Amir, Bar-Chaim, Adina, Benveniste-Levkovitz, Patricia, Levtzion-korach, Osnat
Publicado 2021

Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients

por Efrati, Shai, Catalogna, Merav, Abu Hamed, Ramzia, Hadanny, Amir, Bar-Chaim, Adina, Benveniste-Levkovitz, Patricia, Strugo, Refael, Levtzion-korach, Osnat
Publicado 2021

Population differences in antibody response to SARS‐CoV‐2 infection and BNT162b2 vaccination

por Shapira, Guy, Abu Hamad, Ramzia, Weiner, Chen, Rainy, Nir, Sorek‐Abramovich, Reut, Benveniste‐Levkovitz, Patricia, Rock, Rachel, Avnat, Eden, Levtzion‐Korach, Osnat, Bar Chaim, Adina, Shomron, Noam
Publicado 2022

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021

por Zuckerman, Neta, Nemet, Ital, Kliker, Limor, Atari, Nofar, Lustig, Yaniv, Bucris, Efrat, Bar Ilan, Dana, Geva, Miranda, Sorek-Abramovich, Reut, Weiner, Chen, Rainy, Nir, Bar-Chaim, Adina, Benveniste-Levkovitz, Patricia, Abu Hamed, Ramzia, Regev-Yochay, Gili, Hevkin, Ofra, Mor, Orna, Alroy-Preis, Sharon, Mendelson, Ella, Mandelboim, Michal
Publicado 2021